Vaccination with highly purified cell surface proteins confers protection against experimental group B streptococcal infection

Adv Exp Med Biol. 1997:418:851-3. doi: 10.1007/978-1-4899-1825-3_202.

Authors

C Larsson¹, M Stålhammar-Carlemalm, G Lindahl

Affiliation

¹ Department of Medical Microbiology, Lund University.

PMID: 9331786
DOI: 10.1007/978-1-4899-1825-3_202

No abstract available

MeSH terms

Animals
Antigens, Bacterial*
Bacterial Proteins / immunology*
Bacterial Proteins / isolation & purification
Bacterial Vaccines / isolation & purification
Bacterial Vaccines / pharmacology*
Immunization, Secondary
Male
Membrane Proteins / immunology
Membrane Proteins / isolation & purification
Mice
Mice, Inbred C3H
Serotyping
Streptococcal Infections / immunology
Streptococcal Infections / prevention & control*
Streptococcus agalactiae / classification
Streptococcus agalactiae / immunology*
Streptococcus agalactiae / pathogenicity
Vaccination

Substances

Antigens, Bacterial
Bacterial Proteins
Bacterial Vaccines
Membrane Proteins
Rib protein, Streptococcus agalactiae